Bank of New York Mellon Corp
BankPosition in NBIX — Neurocrine Biosciences Inc
CIK 1390777
NEW YORK, NY
Position in NBIX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$92,546,288
-$12,220,122 QoQ
Shares Held
702,492
-4.9% QoQ
Ownership
0.699%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92.22069432819163.ToString("F0")%
Shared 0.ToString("F0")%
None 7.779305671808362.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,371,862,681 across 46 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in NBIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,546,288 | 702,492 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $104,766,410 | 738,676 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $106,884,763 | 761,396 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $97,865,997 | 778,630 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $91,652,223 | 828,682 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $118,794,581 | 870,290 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $98,887,559 | 858,250 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $128,639,392 | 934,404 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $127,070,515 | 921,335 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $129,000,938 | 979,060 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $173,181,594 | 1,539,392 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $149,862,968 | 1,589,215 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $167,216,346 | 1,652,009 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $201,223,308 | 1,684,723 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $184,906,821 | 1,740,955 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $166,049,082 | 1,703,417 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $159,664,965 | 1,703,093 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $158,585,599 | 1,861,989 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $182,425,320 | 1,902,047 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $196,161,203 | 2,015,631 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $187,901,293 | 1,932,147 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $106,997,900 | 1,112,707 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $118,669,278 | 972,699 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $71,228,655 | 822,977 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||